QUELMIA



Trademark Coverage

Pharmaceutical, Veterinary Products, Dietetic

Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the prevention and treatment of disorders and diseases relating to sensory organs; Pharmaceuticals and medicines for the prevention and treatment of disorders and diseases relating to the central nervous system; Pharmaceuticals and medicines for the prevention and treatment of disorders and diseases relating to urogenital organs; Pharmaceuticals and medicines for the prevention and treatment of disorders and diseases relating to circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism

Owners

ALLERGAN FINANCE, LLC

Business in PARSIPPANY, NJ

Owns 8 trademarks

Actavis, Inc

Business in Parsippany, NJ

Owns 31 trademarks

Timeline
  • Mar 30
    2017
    Notice Of Approval Of Extension Request E Mailed
  • Mar 29
    2017
    Automatic Update Of Assignment Of Ownership
  • Mar 29
    2017
    Extension 2 Granted
  • Mar 22
    2017
    Extension 2 Filed
  • Mar 29
    2017
    Case Assigned To Intent To Use Paralegal
  • Mar 22
    2017
    TEAS Extension Received
  • Jan 30
    2017
    TEAS Change Of Correspondence Received
  • Oct 12
    2016
    Notice Of Approval Of Extension Request E Mailed
  • Oct 10
    2016
    Extension 1 Granted
  • Oct 10
    2016
    Extension 1 Filed
  • Oct 10
    2016
    TEAS Extension Received
  • Apr 19
    2016
    NOA E Mailed SOU Required From Applicant
  • Feb 23
    2016
    Official Gazette Publication Confirmation E Mailed
  • Feb 23
    2016
    Published For Opposition
  • Feb 03
    2016
    Notification Of Notice Of Publication E Mailed
  • Dec 02
    2015
    Approved For PUB Principal Register
  • Dec 02
    2015
    Examiner's Amendment Entered
  • Dec 02
    2015
    Notification Of Examiners Amendment E Mailed
  • Dec 02
    2015
    Examiners Amendment E Mailed
  • Dec 02
    2015
    Examiners Amendment Written
  • Nov 27
    2015
    Assigned To Examiner
  • Aug 19
    2015
    New Application Office Supplied Data Entered In TRAM
  • Aug 17
    2015
    New Application Entered In TRAM